CACNA2D1: A Voltage-Gated Calcium Channel Subunit Alpha-2/Delta-1: A Promising Drug Target and Biomarker

Target Name: CACNA2D1

NCBI ID: G781

CACNA2D1

CACNA2D1: A Voltage-Gated Calcium Channel Subunit Alpha-2/Delta-1: A Promising Drug Target and Biomarker

Abstract:

CACNA2D1, the voltage-gated calcium channel subunit alpha-2/delta-1, has been identified as a promising drug target and biomarker for various neurological and psychiatric disorders. This article summarizes the current understanding of CACNA2D1, its functions, and potential as a drug target.

Introduction:

CACNA2D1, the voltage-gated calcium channel subunit alpha-2/delta-1, is a protein that plays a critical role in the regulation of calcium ions in various cell types. It is a member of the calcium channel subfamily I, which includes other well-known proteins such as CACNA1A, CACNA2, and CACNA3. CACNA2D1 is expressed in a variety of tissues, including neurons, muscle cells, and endothelial cells, and has been implicated in various physiological processes, including muscle contractions, nerve signaling, and blood pressure regulation.

Despite its importance in cell signaling, CACNA2D1 is not well understood, and its functions are still being explored. However, recent studies have identified its potential as a drug target and biomarker for various neurological and psychiatric disorders. In this article, we will summarize the current understanding of CACNA2D1, its functions, and potential as a drug target.

Current Understanding of CACNA2D1:

CACNA2D1 is a voltage-gated calcium channel subunit alpha-2/delta-1 that is expressed in neurons, muscle cells, and other tissues. It is a member of the calcium channel subfamily I and has been implicated in various physiological processes, including muscle contractions, nerve signaling, and blood pressure regulation.

CACNA2D1 functions as a critical regulator of calcium ions in neurons, participating in the regulation of neuronal excitability and synaptic plasticity. It is involved in the regulation of action potential generation and propagation, as well as the regulation of intracellular calcium levels.

Potential as a Drug Target:

Several studies have identified CACNA2D1 as a potential drug target for various neurological and psychiatric disorders. Its functions in neural circuits have been implicated in the pathophysiology of various disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.

One of the potential reasons for targeting CACNA2D1 is its involvement in the regulation of neural plasticity, which is the ability of the nervous system to change and adapt throughout life. Studies have shown that CACNA2D1 is involved in the regulation of synaptic plasticity, including the formation of new neurons and the modulation of existing ones.

In addition, CACNA2D1 has been implicated in the regulation of pain perception and neuroinflammation. Its functions in these areas may be relevant to the development of pain medications and therapies for neuroinflammation.

Potential as a Biomarker:

CACNA2D1 may also be used as a biomarker for various neurological and psychiatric disorders. Its expression and function have been implicated in the pathophysiology of various disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.

One of the potential applications of CACNA2D1 as a biomarker is its potential to serve as a diagnostic marker for these disorders. For example, research has shown that changes in the expression of CACNA2D1 can be detected in the brains of individuals with Alzheimer's disease, which may be used as a diagnostic marker for this disorder.

In addition, CACNA2D1 has

Protein Name: Calcium Voltage-gated Channel Auxiliary Subunit Alpha2delta 1

Functions: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity)

The "CACNA2D1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CACNA2D1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets